Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
Exploration of Targeted Anti-Tumor Therapy|January 6, 2025
Preliminary evaluation of FAPI-04-PET/CT for differentiating recurrence and post-treatment changes in high-grade gliomasIndraja D Dev, Ameya D Puranik, Venkatesh Rangarajan, et al.Frontiers in Nuclear Medicine|October 2, 2024
The complementary role of MRI and FET PET in high-grade gliomas to differentiate recurrence from radionecrosisArpita Sahu, Ronny Mathew, Renuka Ashtekar, et al.Journal of Thoracic Disease|September 11, 2023
Recommended first-line management of asymptomatic brain metastases from EGFR mutant and ALK positive non-small cell lung cancer varies significantly according to specialty: an international survey of clinical practiceChin Heng Fong, Nicholas Meti, Timothy Kruser, et al.Neurosurgery|August 15, 2021
The Initial Step Towards Establishing a Quantitative, Magnetic Resonance Imaging-Based Framework for Response Assessment of Spinal Metastases After Stereotactic Body Radiation TherapyPejman Jabehdar Maralani, Chia-Lin Tseng, Hamidreza Baharjoo, et al.Advances in Radiation Oncology|June 13, 2020
Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain MetastasesMatthew Ramotar, Sierra Barnes, Fabio Moraes, et al.Plos One|July 28, 2020
Quantitative ultrasound radiomics for therapy response monitoring in patients with locally advanced breast cancer: Multi-institutional study resultsKarina Quiaoit, Daniel DiCenzo, Kashuf Fatima, et al.Cancer Medicine|July 1, 2020
Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi-institutional studyDaniel DiCenzo, Karina Quiaoit, Kashuf Fatima, et al.Plos Medicine|May 17, 2024
Radiation enhancement using focussed ultrasound-stimulated microbubbles for breast cancer: A Phase 1 clinical trialDaniel Moore-Palhares, Archya Dasgupta, Murtuza Saifuddin, et al.Neurology India|May 1, 2024
PRRT with Lu-177 DOTATATE in Treatment-Refractory Progressive Meningioma: Initial Experience from a Tertiary-Care Neuro-Oncology CenterAmeya D Puranik, Indraja D Dev, Venkatesh Rangarajan, et al.Neuroradiology|November 11, 2024
FET PET to differentiate between post-treatment changes and recurrence in high-grade gliomas: a single center multidisciplinary clinic controlled studyAmeya D Puranik, Indraja D Dev, Venkatesh Rangarajan, et al.Pageof 9